Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Traws Pharma, Inc. - Common Stock (NQ: TRAW )

6.210 -0.490 (-7.31%)
Streaming Delayed Price Updated: 3:59 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,177
Open 6.710
Bid (Size) 6.100 (1)
Ask (Size) 6.900 (4)
Prev. Close 6.700
Today's Range 6.020 - 6.710
52wk Range 4.060 - 24.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Thursday's pre-market session: top gainers and losers
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Performance

YTD
-28.37%
-28.37%
1 Month
-9.21%
-9.21%
3 Month
+25.96%
+25.96%
6 Month
-35.50%
-35.50%
1 Year
-71.01%
-71.01%

More News

Read More
Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
TRAW Stock Earnings: Traws Pharma Reported Results for Q2 2024
Via InvestorPlace
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
Via Benzinga
Crude Oil Gains 1%; Chicago PMI Falls In December
Via Benzinga
Exposures Fossil Fuels
US Stocks Open Lower; Dow Tumbles 600 Points
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gold Moves Lower, Rumble Shares Jump
Via Benzinga
Nasdaq Surges Over 100 Points, US Durable Goods Orders Decline In November
Via Benzinga
Traws Pharma Stock Rockets On Promising H5N1 Bird Flu Treatment Results
Via Benzinga
US Stocks Mixed, Dow Tumbles 150 Points
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil
From Traws Pharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma, Inc. Announces Special Shareholders Meeting Results
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights
From Traws Pharma, Inc.
Via GlobeNewswire
Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET
From Traws Pharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
From Traws Pharma, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.